BJU International

Papers
(The median citation count of BJU International is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Prolonged ischaemia during partial nephrectomy: impact of warm vs cold96
The impact of post‐nephroureterectomy surgically induced chronic kidney disease on survival outcomes81
MRI in combination with Technetium‐99m‐sestamibi single‐photon emission CT/CT: a novel diagnostic algorithm to maximise the characterisation of small renal masses68
Response to Chen et al.63
Reply to ‘Comment on Bertini et al.: area deprivation and PSA screening disparities’ and ‘Comment on socioeconomic disparities in prostate cancer screening: the impact of the Area Deprivati63
The European Association of Urology talent incubator: bridging competencies for holistic urological care58
Acupuncture: a promising adjuvant strategy for pain management among the patients with prostate cancer56
54
April's reviewers of the month52
Efficacy of RestoreX after prostatectomy: open‐label phase of a randomised controlled trial48
Nephrectomy for kidney tumour increases the risk of de novo arterial hypertension47
Recent key papers in prostate cancer45
The LANDMARK project: providing summaries of key papers that have shaped urological practice44
Editorial Board43
Active surveillance versus enzalutamide for low‐risk prostate cancer – was it really a trial we needed?42
39
Flexible ureterorenoscopy or extracorporeal shockwave lithotripsy in stone disease and bevacizumab for hereditary and sporadic papillary renal‐cell cancer39
Author Index38
September's reviewers of the month36
MRI , Prostate cancer diagnosis, and Artificial Intelligence; What are the implications?35
Age‐related PSA testing for prostate cancer: NICE recommendation 1.6.334
Editorial Board33
Synchronous vs independent reading of prostate‐specific membrane antigen positron emission tomography ( PSMA‐PET) and magnetic resonance imaging ( 33
Vitamin C as an adjunct to methenamine hippurate use after ALTAR: ego or evidence‐based?32
Feasibility and outcomes of interventions to reduce cystoscopy discomfort: a multi‐site pilot study30
Issue Information30
Sexual function in adolescence after childhood hypospadias repair: a patient‐reported outcome study28
Beyond pass or fail: Enhancing the rigour in urological artificial intelligence examination assessment28
Comment on: ‘Residents surgical training using metrics for transurethral resection of bladder tumours’28
ChatGPT – Integrity: Artificial Intelligence Misuse in Medical Writing27
Frail and forgotten: an EAU YAU call for trainee‐led research on frailty in urology27
26
Building a research profile during residency26
Response to comment by Semwal et al.25
Response to comments on ‘Adverse in‐hospital outcomes in patients with paraplegia who undergo radical prostatectomy’25
June's reviewers of the month24
Benchtop comparison of seven ureteroscopes: evaluating physical properties and deflection with flexible and navigable suction access sheaths24
Defining a new national undergraduate urology curriculum in the UK using consensus‐based methodology24
NeuroSAFE in radical prostatectomy increases the rate of nerve‐sparing surgery without affecting oncological outcome24
Patient‐side performance metrics and errors in robotic surgery: Junior‐ European Association of Urology Robotic Urology Section/Young Academic Urologists (J‐ ERUS 24
Aligning germline and somatic mutations in prostate cancer. Are genetics changing practice?23
Eve's and Adam's rib for prostate cancer screening23
Surveillance of non‐muscle ‐invasive bladder cancer with blue‐light cystoscopy: a meta‐analysis23
Impact of the COVID‐19 pandemic on the burnout rates of graduating Canadian Urology residents23
Real‐world performance of Uromonitor® in urothelial bladder cancer detection: a multicentric trial23
‘Igloo’ technique for robot‐assisted radical prostatectomy – maximum nerve sparing for early recovery of continence and sexual function23
Ureterorenoscopy during normothermic machine perfusion: effect of varying renal pelvis pressure22
Non‐significant does not mean uninformative – but poor reporting can be misleading22
The rapid assessment for prostate imaging and diagnosis ( RAPID ) prostate cancer diagnostic pathway22
Area deprivation and cancer‐specific mortality in non‐muscle‐invasive bladder cancer: a statewide analysis22
Prediction Analysis of Microarray of 50 genes ( PAM50) classifier validated for predicting prostate cancer progression in active surveillance: Miami 22
Reply to ‘Comment on novel MRIUS fusion with advanced annotation in focal cryoablation for pros22
Guideline of guidelines: Peyronie's disease22
Opportunistic prostate‐specific antigen testing in Norwegian men: a public health challenge21
A meta‐analysis of Retzius‐sparing and hood‐technique robot‐assisted radical prostatectomy21
Can only AI save us from the burden of administration?21
Validation of a prediction model for post‐chemotherapy fibrosis in nonseminoma patients21
The diagnostic value of MRI for persistent prostate cancer following irreversible electroporation focal therapy20
Analgesic efficacy of rectus sheath catheter is non‐inferior to thoracic epidural catheter20
Sustainability in urology – are we doing enough?20
Comparison of serum and plasma microRNA expression levels in patients with germ cell tumours20
Can exercise increase natural killer cell infiltration of the prostate?19
Table of Contents19
Thulium fibre laser lithotripsy, the new standard?19
September's reviewers of the month19
The effect of different assays on prostate‐specific antigen testing19
Editorial Board18
18
18
August's reviewers of the month18
How prostate‐specific membrane antigen positron emission tomography is refining risk calculators in the primary prostate diagnostic pathway18
Caval thrombectomy a urological leap into the unknown – a call for action18
Why prompting matters: achieving clinically accurate and consistent responses with Chat GPT18
Incidence, risk factors, and temporal trends of penile cancer: a global population‐based study17
Issue Information17
Reply to ‘A mitochondrion‐centric approach to guide treatment de‐escalation in advanced prostate cancer’ by Su et al.17
Artificial intelligence‐based approaches to augmenting and automating surgical training17
Progress in the management of stone disease17
A novel flexible vacuum‐assisted ureteric access sheath in retrograde intrarenal surgery17
Is Gleason 6 cancer? The answer is more than just a ‘name’17
International Alliance of Urolithiasis guideline on retrograde intrarenal surgery17
Lateral drainage metal ureteric stent for the treatment of ‘Y‐shaped’ branch obstructive uropathy16
Quality‐of‐life outcomes of the ROBOtic‐assisted versus Conventional Open Partial nephrectomy (ROBOCOP) II trial16
VI‐RADS followed by Photodynamic Transurethral Resection of Non‐Muscle‐Invasive Bladder Cancer vs White‐Light Conventional and Second‐resection: the ‘CUT‐ less 16
Micro‐ and nanoplastics in the human genitourinary system: oncological impact – a systematic review16
Correction to ‘Complications of vasectomy: results from a prospective audit of 105 393 procedures’16
The prostate cancer electronic health ( eHealth) literacy instrument: a tool for eHealth design an16
Correction to “Outcomes of BCG vs upfront radical cystectomy for high‐risk non‐muscle‐invasive bladder cancer”16
Preferences between three options for androgen deprivation therapy: a focus group study16
Response to: ‘Balancing sheath–scope size in flexible ureteroscopy’16
Comment on ‘Clinical features of medication‐related osteonecrosis of the jaw in prostate cancer management’15
Precision by recognition: smarter firing for better lithotripsy15
Inhibition of phosphodiesterases 1 and 4 prevents myofibroblast transformation in Peyronie's disease15
Ureteric stenting after uncomplicated ureteroscopy: a systematic review of surgeons’ motivations and patient experiences15
Vascular closure devices in living‐donor nephrectomy: a much‐needed systematic review and meta‐analysis focusing on safety15
Sepsis prevalence and associated hospital admission and mortality after ureteroscopy in employed adults15
Evaluating the predictors of poor corporal integrity in penile implant recipients15
Improving detection of carcinoma in situ in bladder cancer: urinary cytology vs the Xpert® BC Monitor15
14
Cystectomy and lymphadenectomy – we now node how far to go!14
Re‐defining the interpretation of 24‐h urine studies for stone formers14
An MRI/PET PSMA‐based phase I–II study of salvage high‐dose‐rate brachytherapy after surgery and radiotherapy14
14
Response to Zhu et al.14
Issue Information14
14
14
Prevalence of germline pathogenic variants in 779 patients with metastatic prostate cancer14
Editorial Board14
Issue Information14
Scribe smarter, not harder: how artificial intelligence scribes stack up against human clinicians14
Editorial Board14
Hydraulic and malleable female‐to‐male penile implants after phalloplasty in transgender individuals: a retrospective cohort analysis13
Functional outcomes of robot‐assisted partial nephrectomy in patients with a solitary kidney13
Urologist underutilisation of androgen receptor pathway inhibitors for metastatic hormone‐sensitive prostate cancer13
BJUI Clinical Dilemma’: Recurrent high‐grade non‐muscle‐invasive bladder cancer in 202613
Response to ‘Endpoint and control group in prostate cancer screening research: public health basics’13
Definitive local therapy for T4 prostate cancer associated with improved local control and survival13
Non‐infectious adverse events of transperineal prostate biopsies performed under local anaesthesia13
Key ingredients for running a randomised controlled trial in a surgical day unit13
Clinical presentation of bacille Calmette–Guérin ( BCG ) infections after 13
Revisiting patient selection and treatment planning in the VIOLETTE trial of targeted microwave ablation13
Developing an artificial intelligence model for phase recognition in robot‐assisted radical prostatectomy13
In vivo ureteroscopic intrarenal pressures and clinical outcomes: a multi‐institutional analysis of 120 consecutive patients13
Case of the Month’ from the First Hospital of Sanming, Fujian Medical University, China: management of a renal haematoma with pyelonephritis and ne13
Mesorectal nodal metastasis with seminal vesicle invasion in biochemically recurrent prostate cancer13
Single‐port robot‐assisted nephroureterectomy via a supine anterior approach: step‐by‐step technique13
Potential safety concerns in use of the artificial intelligence chatbot ‘ChatGPT’ for perioperative patient communication12
Development of an optically transparent kidney model for laser lithotripsy research12
Greenlight laser prostatectomy: which goggles are best for visualising haematuria accurately?12
Table of Contents12
Cisplatin‐ineligible patients with muscle‐invasive bladder cancer demonstrate poor long‐term survival following immediate radical cystectomy12
Bladder irrigation with tap water to reduce antibiotic use for urinary tract infections in catheter users12
There is more to disposable endoscopes than whether they work…12
Long‐term outcomes of cribriform‐positive and cribriform‐negative prostate cancer treated with radical prostatectomy in the ProtecT trial12
Outcomes after laser enucleation of the prostate with and without significant storage symptoms12
Complete response in metastatic renal cell carcinoma: impact of a persistent primary lesion12
Deep learning‐based classification of acute scrotum using single ultrasound images12
The challenges of conducting a surgical trial—reflections on the en bloc resection of urothelium carcinoma of the bladder (EBRUC) II trial12
Google infodemiology and temporal trends in benign prostatic hyperplasia surgery in Australia12
Neural monitoring of central responses to lower urinary tract function12
Use of a microdebrider for epithelial excision during vaginectomy/colpocleisis in patients undergoing metoidioplasty12
Catheterisation after urethral lengthening in transgender/gender‐diverse individuals: a randomised controlled trial (Safe Access for Bladder Entry in Transgender Men Following Penile Reconstruction [ 11
First‐line programmed death receptor‐1 ( PD ‐1) inhibitor and epidermal growth factor receptor (EGFR) blockade, combined with platinum‐based chemothe11
A luminal non‐coding RNA‐based genomic classifier confirms favourable outcomes in patients with clinically organ‐confined bladder cancer treated with radical cystectomy11
Issue Information11
Recovery and immune function after low pressure pneumoperitoneum during robot‐assisted radical prostatectomy: a randomised controlled trial11
Sarcopenia may increase cisplatin toxicity in bladder cancer patients with borderline renal function11
Prognostic value of programmed death ligand‐1 and programmed death‐1 expression in patients with upper tract urothelial carcinoma11
Prophylactic urethrectomy at the time of radical cystectomy for bladder cancer: does it really have an effect on oncological outcomes?11
Comment on ‘Can ChatGPT pass the urology fellowship examination? Artificial intelligence capability in surgical training assessment’11
Surgical cystectomy training using human cadavers embalmed using Thiel's method: a pilot study11
Initial surveillance in men with marker negative clinical stage IIA non‐seminomatous germ cell tumours11
November's reviewers of the month11
F‐SHARP: a Phase I/II trial of focal salvage high‐dose‐rate brachytherapy for Radiorecurrent prostate cancer11
Learning curve for fusion magnetic resonance imaging targeted prostate biopsy and three‐dimensional transrectal ultrasonography segmentation11
Focal therapy using a novel cooled laser device for prostate cancer: early trial results11
Incidence and prognostic implications of PSA relapse after radical radiotherapy for prostate cancer: a population‐based study11
Recommendation on the use of protective eyewear in endourological laser procedures11
Oncological outcomes after attempted nerve‐sparing radical prostatectomy (NSRP) in patients with high‐risk prostate cancer are comparable to standard non‐NSRP: a longitudinal long‐term propensity‐matc10
Deep‐learning segmentation to guide bladder neck recognition in robot‐assisted radical prostatectomy10
Contemporary outcomes in non‐muscle‐invasive bladder cancer: a large European multicentre study10
Fluid management and suction in endourology10
A systematic review on artificial intelligence evaluating PSMA PET scan for intraprostatic cancer10
The value of maintenance therapy in intermediate‐risk non‐muscle‐invasive bladder cancer10
Methodological concerns on prostate‐specific membrane antigen ( PSMA) immunohistochemistry for predicting PSMA 10
Alternate‐day administration of intravesical gemcitabine and docetaxel to improve clinic utilisation10
Iatrogenic ureteric injuries after abdominal surgery: a systematic review and meta‐regression from the European Association of Urology Endourology Section10
Accurate diagnosis of prostate cancer by combining Proclarix with magnetic resonance imaging10
Impact of intraprostatic PSMA maximum standardised uptake value following prostatectomy: a systematic review and meta‐analysis10
Stone volume instead of maximum stone diameter: results from an international survey9
Response to ‘Comment on robot‐assisted partial nephrectomy using the Hugo™ RAS system: first multicentre study’9
Added value of randomised biopsy to multiparametric magnetic resonance imaging‐targeted biopsy of the prostate in a contemporary cohort9
Real‐world outcomes for high‐risk non‐muscle‐invasive bladder cancer: screened patients for the BRAVO trial9
The first step in shared decision‐making for prostate cancer screening9
9
Big trials in prostate cancer | predicting drug response in bladder cancer | immune checkpoint inhibitors for urothelial carcinoma | hydrochlorothiazide in the prevention of kidney stone recurrence9
Total pelvic exenteration surgery for loco‐regionally advanced prostate cancer, is it justifiable?9
Positive surgical margin and oncological outcomes after robot‐assisted radical prostatectomy in different Cancer of the Prostate Risk Assessment risk groups9
Systematic review of PSA reference intervals in the gender diverse population with prostates9
Perspectives on technology: Single‐use catheters – evidence and environmental impact9
What are we missing? Identifying clinically significant prostate cancer among patients with low PSA : the utility of the free‐to‐total 9
Editorial Board9
Re: ‘The perioperative outcomes of papillary versus non‐papillary access in percutaneous nephrolithotomy’9
Editorial Board9
Female non‐obstetric urogenital fistula repair: long‐term patient‐reported outcomes and a scoping literature review9
Irreversible electroporation of localised prostate cancer downregulates immune suppression and induces systemic anti‐tumour T‐cell activation – IRE9
Iatrogenic ureteric injury during abdominal or pelvic surgery: a meta‐analysis9
Issue Information9
June's reviewers of the month9
A comment on: ‘Prevalence of urolithiasis in China: a systematic review and meta‐analysis’9
Response to Daungsupawong and Wiwanitkit: RE: The psychosocial impact of prostate cancer screening for BRCA1 and BRCA2 9
A novel two‐stage approach to the treatment of renal cell carcinoma with intra‐cardiac tumour extension and Budd–Chiari syndrome9
Socioeconomic disparities in prostate cancer screening: the impact of the Area Deprivation Index on PSA screening frequency8
Retzius‐sparing robot‐assisted radical prostatectomy in renal transplant recipients8
May's reviewers of the month8
Metastatic risk in clear cell renal cell carcinoma: a tool incorporating sex, size, and grade8
Patient‐reported outcomes: active surveillance vs radical therapies in low‐risk prostate cancer8
A TREXIT Catalyst: an updated review of NHS England prostate biopsy data during 8
Comment on ‘Renal, bladder and prostate cancer surgery outcomes with respect to team familiarity’8
Trends in treatment and survival of older vs younger patients with renal cancer between 2011 and 20228
Impact of perioperative nutrition on recovery after radical cystectomy: a randomised trial8
Economic analysis of minimally invasive surgical treatments for BPH in the Australian public healthcare system8
A mitochondrion‐centric approach to guide treatment de‐escalation in advanced prostate cancer8
Combined therapy with dutasteride and tadalafil vs dutasteride or tadalafil monotherapy in benign prostatic hyperplasia: a randomised phase III trial8
August's reviewers of the month8
Increasing trend of utilising active surveillance for Gleason Score 7 (3 + 4) prostate cancer8
Issue Information8
8
Stapled vs totally handsewn robotic intracorporeal neobladder: perioperative and functional outcomes8
Alternative instillation techniques of sequential intravesical gemcitabine and docetaxel for non‐muscle‐invasive bladder cancer8
Immunotherapy‐based neoadjuvant treatment and complication rates after radical cystectomy8
A randomized controlled trial investigating rectus sheath catheters following radical cystectomy8
Robot‐assisted single‐port transvesical enucleation of the prostate: step‐by‐step technique and early single‐centre experience8
The growing valuable role of urology clinical nurse specialists in the United Kingdom8
Perspectives on technology: All STEPS count – an integrated framework for net zero urological care7
Journal information7
Alternatives to radical cystectomy: a bladder‐sparing approach in appropriately selected patients7
Intravenously engrafted human multilineage‐differentiating stress‐enduring (Muse) cells rescue erectile function after rat cavernous nerve injury7
Comment on: ‘Preferences between three options for androgen deprivation therapy…’7
Adverse in‐hospital outcomes in patients with paraplegia who undergo radical prostatectomy7
Comment on ‘Stone dust in endourology: a systematic review of its definition, management, and clinical impact’7
Clinical features of medication‐related osteonecrosis of the jaw in prostate cancer management7
The impact of prostate size on single‐port robot‐assisted radical prostatectomy surgical outcomes7
Accuracy of cognitive vs software‐guided MRI ‐targeted biopsy in predicting final grading at prostatectomy7
Uretero‐enteric stricture outcomes: secondary analysis of a randomised controlled trial comparing open versus robot‐assisted radical cystectomy7
Post‐prostatectomy anastomotic stenosis: systematic review and meta‐analysis of endoscopic treatment7
Use of bulbospongiosus muscle for repair of traumatic posterior urethral stenosis combined with urethrorectal fistulas7
Efficacy of indocyanine green fluorescence‐guided inguinal lymph node dissection for penile cancer: a randomised trial7
Low‐ versus standard‐ pneumoperitoneum in patients undergoing robot‐assisted radical prostatectomy: a randomised, triple‐blinded study7
Do not treat Bill Gates for prostate cancer! Algorithmic bias and causality in medical prediction7
Prognostic impact of histological discordance between transurethral resection and radical cystectomy7
Salvage stereotactic ablative body radiotherapy after thermal ablation of primary kidney cancer7
Is solo indocyanine green‐guided lymphadenectomy a feasible alternative to standard pelvic lymph node dissection?7
Cystoscopic application of RADA16 peptide for refractory haematuria from radiation cystitis7
Three‐dimensional virtual reconstruction guides robot‐assisted partial nephrectomy in a horseshoe kidney7
Long‐term multicentre analysis of robot‐assisted radical cystectomy for non‐muscle‐invasive bladder cancer7
Accuracy of MRI in detecting seminal vesicle invasion in prostate cancer: a systematic review and meta‐analysis7
Unravelling the evolution of medical scientific publishing to hold the promise of science for better patient care7
Confocal laser microscopy for assessment of surgical margins during radical prostatectomy7
7
Risks and benefits of partial nephrectomy performed with limited or with zero ischaemia time7
Response to the letter by Kleebayoon et al. Re: Sui et al. ‘Re‐defining the interpretation of 24‐h urine studies for stone formers’7
Is analgesic efficacy of rectus sheath catheter actually non‐inferior to thoracic epidural catheter?7
Impact of audit and feedback on transurethral resection of bladder tumour quality: a monocentric post‐completion evaluation of the RESECT trial7
Long‐term outcomes following a 5‐year recurrence‐free interval in non‐muscle‐invasive bladder cancer7
Depictions of penises in historical paintings reflect changing perceptions of the ideal penis size7
Impact of ischaemia duration and clamping strategy in patients with solitary kidney undergoing partial nephrectomy7
RE : What makes a great urology sub‐internship? A survey of medical students, residents, and faculty7
Subcutaneous local anaesthetic after transperineal prostate biopsy under general anaesthesia : a randomised trial7
0.090187072753906